Analgesics posted positive growth in 2019. More analgesics are targeting specific pain.
There has been a delay in codeine becoming a prescription-only drug in New Zealand, from January 2020 to a date that will be released later by Medsafe, after working with patient groups, health practitioners and healthcare professionals. The delay has been due to concerns that manufacturers would not have enough time to prepare for the changes, and there was a need to publicise the news widely before making it official.
Due to the increasing pursuit of healthy lifestyles and a rise in the number of people going to the gym and playing sports, topical analgesics are growing in demand. This is also one of the fastest growing categories because of the ageing population in New Zealand, and more people using topical analgesics for joint and muscle pain.
Both GlaxoSmithKline and Pfizer have a range of popular pain relief treatments that can be purchased over the counter without a prescription. The companies are, however, not close competitors in New Zealand in analgesics, and there are other competing companies that supply products in the category, thus the Commerce Commission has granted clearance for the acquisition of Pfizer by GlaxoSmithKline.
Although AFT Pharmaceuticals’ sales in New Zealand have declined marginally, the country still accounts for the majority of the company’s sales, along with Australia. The company’s product Maxigesic has been doing well, and distribution has been expanded to other countries, including the UK, Brunei, El Salvador, Israel, Iraq/Kurdistan, Ireland, Italy, Malaysia, Malta, Nicaragua, Serbia, Singapore and the United Arab Emirates.
You have no recently viewed reports.
Why not browse through our Featured or Trending Reports to see what we have to offer?
Discover the latest market trends and uncover sources of future market growth for the Analgesics industry in New Zealand with research from Euromonitor's team of in-country analysts.
Find hidden opportunities in the most current research data available, understand competitive threats with our detailed market analysis, and plan your corporate strategy with our expert qualitative analysis and growth projections.
If you're in the Analgesics industry in New Zealand, our research will save you time and money while empowering you to make informed, profitable decisions.
The Analgesics in New Zealand market research report includes:
Our market research reports answer questions such as:
Why buy this report?
This industry report originates from Passport, our Consumer Health market research database.